Javoy-Agid F - Search Results

1

Is dopaminergic cell death accompanied by concomitant nerve plasticity?

Anglade P, Blanchard V, Raisman-Vozari R, Faucheux BA, Herrero MT, Obeso JA, Mouatt-Prigent A, Kastner A, Strada O, Javoy-Agid F, Agid Y, Hirsch EC. Anglade P, et al. Adv Neurol. 1996;69:195-208. Adv Neurol. 1996. PMID: 8615129 Review. No abstract available.

2

Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw JJ, Agid Y. Hirsch EC, et al. Ann Neurol. 1990 Jun;27(6):676-82. doi: 10.1002/ana.410270615. Ann Neurol. 1990. PMID: 2360804

3

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.

Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC. Anglade P, et al. Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868

4

Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.

Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y. Kastner A, et al. Ann Neurol. 1994 Aug;36(2):206-14. doi: 10.1002/ana.410360213. Ann Neurol. 1994. PMID: 7914399

5

Gangliosides and parkinsonism.

Herrero MT, Kastner A, Perez-Otaño I, Hirsch EC, Luquin MR, Javoy-Agid F, Del Río J, Obeso JA, Agid Y. Herrero MT, et al. Neurology. 1993 Oct;43(10):2132-4. doi: 10.1212/wnl.43.10.2132. Neurology. 1993. PMID: 8413979

6

Are dopaminergic neurons selectively vulnerable to Parkinson's disease?

Agid Y, Ruberg M, Javoy-Agid F, Hirsch E, Raisman-Vozari R, Vyas S, Faucheux B, Michel P, Kastner A, Blanchard V, et al. Agid Y, et al. Adv Neurol. 1993;60:148-64. Adv Neurol. 1993. PMID: 8420132 Review. No abstract available.

7

Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.

Vila M, Herrero MT, Levy R, Faucheux B, Ruberg M, Guillen J, Luquin MR, Guridi J, Javoy-Agid F, Agid Y, Obeso JA, Hirsch EC. Vila M, et al. Among authors: javoy agid f. Neurology. 1996 Mar;46(3):802-9. doi: 10.1212/wnl.46.3.802. Neurology. 1996. PMID: 8618687

8

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Kastner A, et al. J Neurochem. 1992 Sep;59(3):1080-9. doi: 10.1111/j.1471-4159.1992.tb08350.x. J Neurochem. 1992. PMID: 1494900

9

Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.

Malessa S, Hirsch EC, Cervera P, Javoy-Agid F, Duyckaerts C, Hauw JJ, Agid Y. Malessa S, et al. Neurology. 1991 Oct;41(10):1593-7. doi: 10.1212/wnl.41.10.1593. Neurology. 1991. PMID: 1922800

10

The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?

Agid Y, Graybiel AM, Ruberg M, Hirsch E, Blin J, Dubois B, Javoy-Agid F. Agid Y, et al. Adv Neurol. 1990;53:83-100. Adv Neurol. 1990. PMID: 1978522 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters